Medical progress: Primary biliary cirrhosis

[1] Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (12) : 1645 - 1652

[2] Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (10) : 6444 - 6452

[3] Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid [J]. HEPATOLOGY, 2000, 31 (02) : 318 - 323

[4] Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid [J]. HEPATOLOGY, 2000, 32 (05) : 897 - 900

[5] [Anonymous], 1993, J Hepatol, V17, P227

[6] Bergasa Nora V, 2003, Clin Liver Dis, V7, P879, DOI 10.1016/S1089-3261(03)00105-3

[7] Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (08) : 873 - 878

[8] Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol [J]. GASTROENTEROLOGY, 1999, 117 (02) : 395 - 399

[9] Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (05) : 551 - 557

[10] EFFECT OF DISTAL SPLENORENAL SHUNT ON SURVIVAL OF PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS [J]. HEPATOLOGY, 1994, 20 (06) : 1482 - 1486

[1] Multicentre randomized placebo-controlled trial of ursodeoxycholic acid with or without colchicine in symptomatic primary biliary cirrhosis [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (12) : 1645 - 1652

[2] Xenobiotic-induced loss of tolerance in rabbits to the mitochondrial autoantigen of primary biliary cirrhosis is reversible [J]. JOURNAL OF IMMUNOLOGY, 2004, 172 (10) : 6444 - 6452

[3] Oral budesonide in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid [J]. HEPATOLOGY, 2000, 31 (02) : 318 - 323

[4] Silymarin in the treatment of patients with primary biliary cirrhosis with a suboptimal response to ursodeoxycholic acid [J]. HEPATOLOGY, 2000, 32 (05) : 897 - 900

[5] [Anonymous], 1993, J Hepatol, V17, P227

[6] Bergasa Nora V, 2003, Clin Liver Dis, V7, P879, DOI 10.1016/S1089-3261(03)00105-3

[7] Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2004, 19 (08) : 873 - 878

[8] Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol [J]. GASTROENTEROLOGY, 1999, 117 (02) : 395 - 399

[9] Fracture risk of women with primary biliary cirrhosis: no increase compared with general population controls [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 20 (05) : 551 - 557

[10] EFFECT OF DISTAL SPLENORENAL SHUNT ON SURVIVAL OF PATIENTS WITH PRIMARY BILIARY-CIRRHOSIS [J]. HEPATOLOGY, 1994, 20 (06) : 1482 - 1486